Global Pharma and Health Care Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 268285
  • calendar_today Published On: Jan, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Pharma and Health Care market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Pharma and Health Care market size is estimated to be worth US$ 1281950 million in 2021 and is forecast to a readjusted size of USD 1667520 million by 2028 with a CAGR of 3.8% during review period. OTC Drugs accounting for % of the Pharma and Health Care global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Bottle segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Pharma and Health Care include Johnson & Johnson, Novartis, Roche, AbbVie, and Merck & Co., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Pharma and Health Care market is split by Format and by Prescription. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Format and by Prescription. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Format, covers

Bottle

Blister

Others

Market segment by Prescription, can be divided into

OTC Drugs

Prescription Drugs

Market segment by players, this report covers

Johnson & Johnson

Novartis

Roche

AbbVie

Merck & Co.

Bristol Myers Squibb

GlaxoSmithKline

Pfizer

Sanofi

Takeda

AstraZeneca

Bayer

Eli Lilly & Co.

Gilead Sciences

Amgen

Novo Nordisk

Teva

Boehringer Ingelheim

Biogen

Astellas

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Pharma and Health Care product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Pharma and Health Care, with revenue, gross margin and global market share of Pharma and Health Care from 2019 to 2022.

Chapter 3, the Pharma and Health Care competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Format and application, with revenue and growth rate by Format, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pharma and Health Care market forecast, by regions, format and prescription, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Pharma and Health Care research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Pharma and Health Care

1.2 Classification of Pharma and Health Care by Format

1.2.1 Overview: Global Pharma and Health Care Market Size by Format: 2017 Versus 2021 Versus 2028

1.2.2 Global Pharma and Health Care Revenue Market Share by Format in 2021

1.2.3 Bottle

1.2.4 Blister

1.2.5 Others

1.3 Global Pharma and Health Care Market by Prescription

1.3.1 Overview: Global Pharma and Health Care Market Size by Prescription: 2017 Versus 2021 Versus 2028

1.3.2 OTC Drugs

1.3.3 Prescription Drugs

1.4 Global Pharma and Health Care Market Size & Forecast

1.5 Global Pharma and Health Care Market Size and Forecast by Region

1.5.1 Global Pharma and Health Care Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Pharma and Health Care Market Size by Region, (2017-2022)

1.5.3 North America Pharma and Health Care Market Size and Prospect (2017-2028)

1.5.4 Europe Pharma and Health Care Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Pharma and Health Care Market Size and Prospect (2017-2028)

1.5.6 South America Pharma and Health Care Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Pharma and Health Care Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Pharma and Health Care Market Drivers

1.6.2 Pharma and Health Care Market Restraints

1.6.3 Pharma and Health Care Trends Analysis

2 Company Profiles

2.1 Johnson & Johnson

2.1.1 Johnson & Johnson Details

2.1.2 Johnson & Johnson Major Business

2.1.3 Johnson & Johnson Pharma and Health Care Product and Solutions

2.1.4 Johnson & Johnson Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Johnson & Johnson Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Pharma and Health Care Product and Solutions

2.2.4 Novartis Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Novartis Recent Developments and Future Plans

2.3 Roche

2.3.1 Roche Details

2.3.2 Roche Major Business

2.3.3 Roche Pharma and Health Care Product and Solutions

2.3.4 Roche Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Roche Recent Developments and Future Plans

2.4 AbbVie

2.4.1 AbbVie Details

2.4.2 AbbVie Major Business

2.4.3 AbbVie Pharma and Health Care Product and Solutions

2.4.4 AbbVie Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 AbbVie Recent Developments and Future Plans

2.5 Merck & Co.

2.5.1 Merck & Co. Details

2.5.2 Merck & Co. Major Business

2.5.3 Merck & Co. Pharma and Health Care Product and Solutions

2.5.4 Merck & Co. Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Merck & Co. Recent Developments and Future Plans

2.6 Bristol Myers Squibb

2.6.1 Bristol Myers Squibb Details

2.6.2 Bristol Myers Squibb Major Business

2.6.3 Bristol Myers Squibb Pharma and Health Care Product and Solutions

2.6.4 Bristol Myers Squibb Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Bristol Myers Squibb Recent Developments and Future Plans

2.7 GlaxoSmithKline

2.7.1 GlaxoSmithKline Details

2.7.2 GlaxoSmithKline Major Business

2.7.3 GlaxoSmithKline Pharma and Health Care Product and Solutions

2.7.4 GlaxoSmithKline Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 GlaxoSmithKline Recent Developments and Future Plans

2.8 Pfizer

2.8.1 Pfizer Details

2.8.2 Pfizer Major Business

2.8.3 Pfizer Pharma and Health Care Product and Solutions

2.8.4 Pfizer Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Pfizer Recent Developments and Future Plans

2.9 Sanofi

2.9.1 Sanofi Details

2.9.2 Sanofi Major Business

2.9.3 Sanofi Pharma and Health Care Product and Solutions

2.9.4 Sanofi Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Sanofi Recent Developments and Future Plans

2.10 Takeda

2.10.1 Takeda Details

2.10.2 Takeda Major Business

2.10.3 Takeda Pharma and Health Care Product and Solutions

2.10.4 Takeda Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Takeda Recent Developments and Future Plans

2.11 AstraZeneca

2.11.1 AstraZeneca Details

2.11.2 AstraZeneca Major Business

2.11.3 AstraZeneca Pharma and Health Care Product and Solutions

2.11.4 AstraZeneca Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 AstraZeneca Recent Developments and Future Plans

2.12 Bayer

2.12.1 Bayer Details

2.12.2 Bayer Major Business

2.12.3 Bayer Pharma and Health Care Product and Solutions

2.12.4 Bayer Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Bayer Recent Developments and Future Plans

2.13 Eli Lilly & Co.

2.13.1 Eli Lilly & Co. Details

2.13.2 Eli Lilly & Co. Major Business

2.13.3 Eli Lilly & Co. Pharma and Health Care Product and Solutions

2.13.4 Eli Lilly & Co. Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Eli Lilly & Co. Recent Developments and Future Plans

2.14 Gilead Sciences

2.14.1 Gilead Sciences Details

2.14.2 Gilead Sciences Major Business

2.14.3 Gilead Sciences Pharma and Health Care Product and Solutions

2.14.4 Gilead Sciences Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Gilead Sciences Recent Developments and Future Plans

2.15 Amgen

2.15.1 Amgen Details

2.15.2 Amgen Major Business

2.15.3 Amgen Pharma and Health Care Product and Solutions

2.15.4 Amgen Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Amgen Recent Developments and Future Plans

2.16 Novo Nordisk

2.16.1 Novo Nordisk Details

2.16.2 Novo Nordisk Major Business

2.16.3 Novo Nordisk Pharma and Health Care Product and Solutions

2.16.4 Novo Nordisk Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Novo Nordisk Recent Developments and Future Plans

2.17 Teva

2.17.1 Teva Details

2.17.2 Teva Major Business

2.17.3 Teva Pharma and Health Care Product and Solutions

2.17.4 Teva Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Teva Recent Developments and Future Plans

2.18 Boehringer Ingelheim

2.18.1 Boehringer Ingelheim Details

2.18.2 Boehringer Ingelheim Major Business

2.18.3 Boehringer Ingelheim Pharma and Health Care Product and Solutions

2.18.4 Boehringer Ingelheim Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Boehringer Ingelheim Recent Developments and Future Plans

2.19 Biogen

2.19.1 Biogen Details

2.19.2 Biogen Major Business

2.19.3 Biogen Pharma and Health Care Product and Solutions

2.19.4 Biogen Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Biogen Recent Developments and Future Plans

2.20 Astellas

2.20.1 Astellas Details

2.20.2 Astellas Major Business

2.20.3 Astellas Pharma and Health Care Product and Solutions

2.20.4 Astellas Pharma and Health Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 Astellas Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Pharma and Health Care Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Pharma and Health Care Players Market Share in 2021

3.2.2 Top 10 Pharma and Health Care Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Pharma and Health Care Players Head Office, Products and Services Provided

3.4 Pharma and Health Care Mergers & Acquisitions

3.5 Pharma and Health Care New Entrants and Expansion Plans

4 Market Size Segment by Format

4.1 Global Pharma and Health Care Revenue and Market Share by Format (2017-2022)

4.2 Global Pharma and Health Care Market Forecast by Format (2023-2028)

5 Market Size Segment by Prescription

5.1 Global Pharma and Health Care Revenue Market Share by Prescription (2017-2022)

5.2 Global Pharma and Health Care Market Forecast by Prescription (2023-2028)

6 North America by Country, by Format, and by Prescription

6.1 North America Pharma and Health Care Revenue by Format (2017-2028)

6.2 North America Pharma and Health Care Revenue by Prescription (2017-2028)

6.3 North America Pharma and Health Care Market Size by Country

6.3.1 North America Pharma and Health Care Revenue by Country (2017-2028)

6.3.2 United States Pharma and Health Care Market Size and Forecast (2017-2028)

6.3.3 Canada Pharma and Health Care Market Size and Forecast (2017-2028)

6.3.4 Mexico Pharma and Health Care Market Size and Forecast (2017-2028)

7 Europe by Country, by Format, and by Prescription

7.1 Europe Pharma and Health Care Revenue by Format (2017-2028)

7.2 Europe Pharma and Health Care Revenue by Prescription (2017-2028)

7.3 Europe Pharma and Health Care Market Size by Country

7.3.1 Europe Pharma and Health Care Revenue by Country (2017-2028)

7.3.2 Germany Pharma and Health Care Market Size and Forecast (2017-2028)

7.3.3 France Pharma and Health Care Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Pharma and Health Care Market Size and Forecast (2017-2028)

7.3.5 Russia Pharma and Health Care Market Size and Forecast (2017-2028)

7.3.6 Italy Pharma and Health Care Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Format, and by Prescription

8.1 Asia-Pacific Pharma and Health Care Revenue by Format (2017-2028)

8.2 Asia-Pacific Pharma and Health Care Revenue by Prescription (2017-2028)

8.3 Asia-Pacific Pharma and Health Care Market Size by Region

8.3.1 Asia-Pacific Pharma and Health Care Revenue by Region (2017-2028)

8.3.2 China Pharma and Health Care Market Size and Forecast (2017-2028)

8.3.3 Japan Pharma and Health Care Market Size and Forecast (2017-2028)

8.3.4 South Korea Pharma and Health Care Market Size and Forecast (2017-2028)

8.3.5 India Pharma and Health Care Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Pharma and Health Care Market Size and Forecast (2017-2028)

8.3.7 Australia Pharma and Health Care Market Size and Forecast (2017-2028)

9 South America by Country, by Format, and by Prescription

9.1 South America Pharma and Health Care Revenue by Format (2017-2028)

9.2 South America Pharma and Health Care Revenue by Prescription (2017-2028)

9.3 South America Pharma and Health Care Market Size by Country

9.3.1 South America Pharma and Health Care Revenue by Country (2017-2028)

9.3.2 Brazil Pharma and Health Care Market Size and Forecast (2017-2028)

9.3.3 Argentina Pharma and Health Care Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Format, and by Prescription

10.1 Middle East & Africa Pharma and Health Care Revenue by Format (2017-2028)

10.2 Middle East & Africa Pharma and Health Care Revenue by Prescription (2017-2028)

10.3 Middle East & Africa Pharma and Health Care Market Size by Country

10.3.1 Middle East & Africa Pharma and Health Care Revenue by Country (2017-2028)

10.3.2 Turkey Pharma and Health Care Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Pharma and Health Care Market Size and Forecast (2017-2028)

10.3.4 UAE Pharma and Health Care Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Pharma and Health Care Revenue by Format, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Pharma and Health Care Revenue by Prescription, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Pharma and Health Care Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Pharma and Health Care Revenue (USD Million) by Region (2017-2022)

Table 5. Global Pharma and Health Care Revenue Market Share by Region (2023-2028)

Table 6. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 7. Johnson & Johnson Major Business

Table 8. Johnson & Johnson Pharma and Health Care Product and Solutions

Table 9. Johnson & Johnson Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis Pharma and Health Care Product and Solutions

Table 13. Novartis Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Roche Corporate Information, Head Office, and Major Competitors

Table 15. Roche Major Business

Table 16. Roche Pharma and Health Care Product and Solutions

Table 17. Roche Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. AbbVie Corporate Information, Head Office, and Major Competitors

Table 19. AbbVie Major Business

Table 20. AbbVie Pharma and Health Care Product and Solutions

Table 21. AbbVie Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Merck & Co. Corporate Information, Head Office, and Major Competitors

Table 23. Merck & Co. Major Business

Table 24. Merck & Co. Pharma and Health Care Product and Solutions

Table 25. Merck & Co. Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Bristol Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 27. Bristol Myers Squibb Major Business

Table 28. Bristol Myers Squibb Pharma and Health Care Product and Solutions

Table 29. Bristol Myers Squibb Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 31. GlaxoSmithKline Major Business

Table 32. GlaxoSmithKline Pharma and Health Care Product and Solutions

Table 33. GlaxoSmithKline Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Pfizer Corporate Information, Head Office, and Major Competitors

Table 35. Pfizer Major Business

Table 36. Pfizer Pharma and Health Care Product and Solutions

Table 37. Pfizer Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Sanofi Corporate Information, Head Office, and Major Competitors

Table 39. Sanofi Major Business

Table 40. Sanofi Pharma and Health Care Product and Solutions

Table 41. Sanofi Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Takeda Corporate Information, Head Office, and Major Competitors

Table 43. Takeda Major Business

Table 44. Takeda Pharma and Health Care Product and Solutions

Table 45. Takeda Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 47. AstraZeneca Major Business

Table 48. AstraZeneca Pharma and Health Care Product and Solutions

Table 49. AstraZeneca Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Bayer Corporate Information, Head Office, and Major Competitors

Table 51. Bayer Major Business

Table 52. Bayer Pharma and Health Care Product and Solutions

Table 53. Bayer Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Eli Lilly & Co. Corporate Information, Head Office, and Major Competitors

Table 55. Eli Lilly & Co. Major Business

Table 56. Eli Lilly & Co. Pharma and Health Care Product and Solutions

Table 57. Eli Lilly & Co. Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Gilead Sciences Corporate Information, Head Office, and Major Competitors

Table 59. Gilead Sciences Major Business

Table 60. Gilead Sciences Pharma and Health Care Product and Solutions

Table 61. Gilead Sciences Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Amgen Corporate Information, Head Office, and Major Competitors

Table 63. Amgen Major Business

Table 64. Amgen Pharma and Health Care Product and Solutions

Table 65. Amgen Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 67. Novo Nordisk Major Business

Table 68. Novo Nordisk Pharma and Health Care Product and Solutions

Table 69. Novo Nordisk Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Teva Corporate Information, Head Office, and Major Competitors

Table 71. Teva Major Business

Table 72. Teva Pharma and Health Care Product and Solutions

Table 73. Teva Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 75. Boehringer Ingelheim Major Business

Table 76. Boehringer Ingelheim Pharma and Health Care Product and Solutions

Table 77. Boehringer Ingelheim Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Biogen Corporate Information, Head Office, and Major Competitors

Table 79. Biogen Major Business

Table 80. Biogen Pharma and Health Care Product and Solutions

Table 81. Biogen Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Astellas Corporate Information, Head Office, and Major Competitors

Table 83. Astellas Major Business

Table 84. Astellas Pharma and Health Care Product and Solutions

Table 85. Astellas Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. Global Pharma and Health Care Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 87. Global Pharma and Health Care Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 88. Breakdown of Pharma and Health Care by Company Type (Tier 1, Tier 2 and Tier 3)

Table 89. Pharma and Health Care Players Head Office, Products and Services Provided

Table 90. Pharma and Health Care Mergers & Acquisitions in the Past Five Years

Table 91. Pharma and Health Care New Entrants and Expansion Plans

Table 92. Global Pharma and Health Care Revenue (USD Million) by Format (2017-2022)

Table 93. Global Pharma and Health Care Revenue Share by Format (2017-2022)

Table 94. Global Pharma and Health Care Revenue Forecast by Format (2023-2028)

Table 95. Global Pharma and Health Care Revenue by Prescription (2017-2022)

Table 96. Global Pharma and Health Care Revenue Forecast by Prescription (2023-2028)

Table 97. North America Pharma and Health Care Revenue by Format (2017-2022) & (USD Million)

Table 98. North America Pharma and Health Care Revenue by Format (2023-2028) & (USD Million)

Table 99. North America Pharma and Health Care Revenue by Prescription (2017-2022) & (USD Million)

Table 100. North America Pharma and Health Care Revenue by Prescription (2023-2028) & (USD Million)

Table 101. North America Pharma and Health Care Revenue by Country (2017-2022) & (USD Million)

Table 102. North America Pharma and Health Care Revenue by Country (2023-2028) & (USD Million)

Table 103. Europe Pharma and Health Care Revenue by Format (2017-2022) & (USD Million)

Table 104. Europe Pharma and Health Care Revenue by Format (2023-2028) & (USD Million)

Table 105. Europe Pharma and Health Care Revenue by Prescription (2017-2022) & (USD Million)

Table 106. Europe Pharma and Health Care Revenue by Prescription (2023-2028) & (USD Million)

Table 107. Europe Pharma and Health Care Revenue by Country (2017-2022) & (USD Million)

Table 108. Europe Pharma and Health Care Revenue by Country (2023-2028) & (USD Million)

Table 109. Asia-Pacific Pharma and Health Care Revenue by Format (2017-2022) & (USD Million)

Table 110. Asia-Pacific Pharma and Health Care Revenue by Format (2023-2028) & (USD Million)

Table 111. Asia-Pacific Pharma and Health Care Revenue by Prescription (2017-2022) & (USD Million)

Table 112. Asia-Pacific Pharma and Health Care Revenue by Prescription (2023-2028) & (USD Million)

Table 113. Asia-Pacific Pharma and Health Care Revenue by Region (2017-2022) & (USD Million)

Table 114. Asia-Pacific Pharma and Health Care Revenue by Region (2023-2028) & (USD Million)

Table 115. South America Pharma and Health Care Revenue by Format (2017-2022) & (USD Million)

Table 116. South America Pharma and Health Care Revenue by Format (2023-2028) & (USD Million)

Table 117. South America Pharma and Health Care Revenue by Prescription (2017-2022) & (USD Million)

Table 118. South America Pharma and Health Care Revenue by Prescription (2023-2028) & (USD Million)

Table 119. South America Pharma and Health Care Revenue by Country (2017-2022) & (USD Million)

Table 120. South America Pharma and Health Care Revenue by Country (2023-2028) & (USD Million)

Table 121. Middle East & Africa Pharma and Health Care Revenue by Format (2017-2022) & (USD Million)

Table 122. Middle East & Africa Pharma and Health Care Revenue by Format (2023-2028) & (USD Million)

Table 123. Middle East & Africa Pharma and Health Care Revenue by Prescription (2017-2022) & (USD Million)

Table 124. Middle East & Africa Pharma and Health Care Revenue by Prescription (2023-2028) & (USD Million)

Table 125. Middle East & Africa Pharma and Health Care Revenue by Country (2017-2022) & (USD Million)

Table 126. Middle East & Africa Pharma and Health Care Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Pharma and Health Care Picture

Figure 2. Global Pharma and Health Care Revenue Market Share by Format in 2021

Figure 3. Bottle

Figure 4. Blister

Figure 5. Others

Figure 6. Pharma and Health Care Revenue Market Share by Prescription in 2021

Figure 7. OTC Drugs Picture

Figure 8. Prescription Drugs Picture

Figure 9. Global Pharma and Health Care Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Pharma and Health Care Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Pharma and Health Care Revenue Market Share by Region (2017-2028)

Figure 12. Global Pharma and Health Care Revenue Market Share by Region in 2021

Figure 13. North America Pharma and Health Care Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Pharma and Health Care Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Pharma and Health Care Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Pharma and Health Care Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Pharma and Health Care Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Pharma and Health Care Market Drivers

Figure 19. Pharma and Health Care Market Restraints

Figure 20. Pharma and Health Care Market Trends

Figure 21. Johnson & Johnson Recent Developments and Future Plans

Figure 22. Novartis Recent Developments and Future Plans

Figure 23. Roche Recent Developments and Future Plans

Figure 24. AbbVie Recent Developments and Future Plans

Figure 25. Merck & Co. Recent Developments and Future Plans

Figure 26. Bristol Myers Squibb Recent Developments and Future Plans

Figure 27. GlaxoSmithKline Recent Developments and Future Plans

Figure 28. Pfizer Recent Developments and Future Plans

Figure 29. Sanofi Recent Developments and Future Plans

Figure 30. Takeda Recent Developments and Future Plans

Figure 31. AstraZeneca Recent Developments and Future Plans

Figure 32. Bayer Recent Developments and Future Plans

Figure 33. Eli Lilly & Co. Recent Developments and Future Plans

Figure 34. Gilead Sciences Recent Developments and Future Plans

Figure 35. Amgen Recent Developments and Future Plans

Figure 36. Novo Nordisk Recent Developments and Future Plans

Figure 37. Teva Recent Developments and Future Plans

Figure 38. Boehringer Ingelheim Recent Developments and Future Plans

Figure 39. Biogen Recent Developments and Future Plans

Figure 40. Astellas Recent Developments and Future Plans

Figure 41. Global Pharma and Health Care Revenue Share by Players in 2021

Figure 42. Pharma and Health Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 43. Global Top 3 Players Pharma and Health Care Revenue Market Share in 2021

Figure 44. Global Top 10 Players Pharma and Health Care Revenue Market Share in 2021

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 46. Global Pharma and Health Care Revenue Share by Format in 2021

Figure 47. Global Pharma and Health Care Market Share Forecast by Format (2023-2028)

Figure 48. Global Pharma and Health Care Revenue Share by Prescription in 2021

Figure 49. Global Pharma and Health Care Market Share Forecast by Prescription (2023-2028)

Figure 50. North America Pharma and Health Care Sales Market Share by Format (2017-2028)

Figure 51. North America Pharma and Health Care Sales Market Share by Prescription (2017-2028)

Figure 52. North America Pharma and Health Care Revenue Market Share by Country (2017-2028)

Figure 53. United States Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Canada Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Mexico Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Europe Pharma and Health Care Sales Market Share by Format (2017-2028)

Figure 57. Europe Pharma and Health Care Sales Market Share by Prescription (2017-2028)

Figure 58. Europe Pharma and Health Care Revenue Market Share by Country (2017-2028)

Figure 59. Germany Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. France Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. United Kingdom Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Russia Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Italy Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Asia-Pacific Pharma and Health Care Sales Market Share by Format (2017-2028)

Figure 65. Asia-Pacific Pharma and Health Care Sales Market Share by Prescription (2017-2028)

Figure 66. Asia-Pacific Pharma and Health Care Revenue Market Share by Region (2017-2028)

Figure 67. China Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Japan Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South Korea Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. India Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Southeast Asia Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Australia Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. South America Pharma and Health Care Sales Market Share by Format (2017-2028)

Figure 74. South America Pharma and Health Care Sales Market Share by Prescription (2017-2028)

Figure 75. South America Pharma and Health Care Revenue Market Share by Country (2017-2028)

Figure 76. Brazil Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Argentina Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Middle East and Africa Pharma and Health Care Sales Market Share by Format (2017-2028)

Figure 79. Middle East and Africa Pharma and Health Care Sales Market Share by Prescription (2017-2028)

Figure 80. Middle East and Africa Pharma and Health Care Revenue Market Share by Country (2017-2028)

Figure 81. Turkey Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Saudi Arabia Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. UAE Pharma and Health Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source